• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Transl Med . Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

tetano

Editor, Senior Moderator
Sci Transl Med


. 2020 Sep 21;eabd5487.
doi: 10.1126/scitranslmed.abd5487. Online ahead of print.
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients


Carl A Pierce[SUP] 1 [/SUP], Paula Preston-Hurlburt[SUP] 1 [/SUP], Yile Dai[SUP] 1 [/SUP], Clare Burn Aschner[SUP] 2 [/SUP], Natalia Cheshenko[SUP] 3 [/SUP], Benjamin Galen[SUP] 4 [/SUP], Scott J Garforth[SUP] 5 [/SUP], Natalia G Herrera[SUP] 5 [/SUP], Rohit K Jangra[SUP] 2 [/SUP], Nicholas C Morano[SUP] 5 [/SUP], Erika Orner[SUP] 6 [/SUP], Sharlene Sy[SUP] 3 [/SUP], Kartik Chandran[SUP] 2 [/SUP], James Dziura[SUP] 7 [/SUP], Steven C Almo[SUP] 5 [/SUP], Aaron Ring[SUP] 1 [/SUP], Marla J Keller[SUP] 4 [/SUP], Kevan C Herold[SUP] #[/SUP][SUP] 8 7 [/SUP], Betsy C Herold[SUP] #[/SUP][SUP] 9 3 [/SUP]



Affiliations

Abstract

Children and youth infected with SARS-CoV-2 have milder disease than do adults and, even among those with the recently described multi-system inflammatory syndrome (MIS-C), mortality is rare. The reasons for the differences in clinical manifestations are unknown, but suggest that age-dependent factors may modulate the anti-viral immune response. We compared cytokine, humoral, and cellular immune responses in pediatric (children and youth, age < 24 years) (n=65) and adult (n=60) patients with COVID-19 at a metropolitan hospital system in New York City. The pediatric patients had a shorter length of stay, decreased requirement for mechanical ventilation and lower mortality compared to adults. The serum concentrations of IL-17A and IFN-γ, but not TNF-α or IL-6, were inversely related to age. Adults mounted a more robust T cell response to the viral spike protein compared to pediatric patients as evidenced by increased expression of CD25+ on CD4+ T cells and the frequency of IFN-γ+CD4+ T cells. Moreover, serum neutralizing antibody titers and antibody-dependent cellular phagocytosis were higher in adults compared to pediatric COVID-19 patients. The neutralizing antibody titer correlated positively with age and negatively with IL-17A and IFN-γ serum concentrations. There were no differences in anti-spike protein antibody titers to other human coronaviruses. Together these findings demonstrate that the poor outcome in hospitalized adults with COVID-19 compared to children may not be attributable to a failure to generate adaptive immune responses.
 
Back
Top Bottom